About Mapi Group
Mapi Group is a company based in Lyon (France) founded in 1990 was acquired by Icon in July 2017. Mapi Group has raised $8.43 million across 1 funding round from investors including ICON and Bryan, Garnier & Co. Mapi Group operates in a competitive market with competitors including ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.
- Headquarter Lyon, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Mapi Group
Mapi Group has successfully raised a total of $8.43M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $8.43 million completed in June 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mapi Group
Mapi Group has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include ICON and Bryan, Garnier & Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Full service boutique investment bank
|
Locked | Locked | Locked | |
|
ICON plc is engaged in clinical research and drug development services.
|
Locked | Locked | Locked |
Investor details for Mapi Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mapi Group
Investment portfolio details for Mapi Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mapi Group
Detailed financials for Mapi Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mapi Group Comparisons
Peer comparison for Mapi Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mapi Group
Mapi Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device
|
|
| Locked | Locked | Locked |
Regulatory, compliance, and quality consulting for GxP lifecycles is provided.
|
|
| Locked | Locked | Locked |
CRO specializing in regulatory affairs and pharmacovigilance
|
|
| Locked | Locked | Locked |
Healthcare instrumentation, medical gas systems, and related devices are manufactured.
|
|
| Locked | Locked | Locked |
Regulatory consulting and solutions for pharmaceuticals and medical devices compliance.
|
|
| Locked | Locked | Locked |
Regulatory support and consulting services are provided for clinical outcomes.
|
Detailed competitors of Mapi Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mapi Group
Complete news archive for Mapi Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mapi Group
Mapi Group was founded in 1990 and raised its 1st funding round 15 years after it was founded.
Mapi Group is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Mapi Group is a funded company, having raised a total of $8.43M across 1 funding round to date.
Mapi Group is a provider of patient centric research services such as real world evidence, market access and health economics and outcomes research, real world strategy, and analytics, language services and strategic regulatory services (including pharmacovigilance) and global late phase research services. The company claims to have expertise in the design and conduct of post approval and commercialization programs for pharmaceuticals, biologics and medical devices. Mapis research trust has more than 4000 COAs (Clinical Outcomes Assessments), 40,000 COA translations, and a research library with more than 29,000 COAs. The company claims to have expertise in rare diseases and gastrointestinal research. The company was acquired by ICON in 2017.
Mapi Group's top competitors include ProPharma Group, PharmaLex and Pharma-Bio Serv.
Mapi Group has 2 investors. Key investors include ICON, and Bryan, Garnier & Co.